October 2, 2012
Takeda Pharmaceutical on September 28 announced that it received approval on the same day for the hyperlipidemia treatment Lotriga granular capsule 2 g (omega 3-acid ethyl esters 90). Lotriga, an omega 3-derived drug containing highly purified eicosapentaenoic acid ethyl ester...read more